Highlights from recent Life Science venture capital news.
First Venture Round
18.01.2012 – Cambridge, MA
RaNA Therapeutics Closes $20.7M Series A Financing
RaNA Therapeutics, a Cambridge, Mass.-based company that is developing drugs by modulating disease-associated long non-coding RNA (lncRNA) and restoring normal expression of individual targeted genes, has completed a $20.7m Series A financing. The round was co-led by Atlas Venture, SR One, and Monsanto, with participation of Partners Innovation Fund. http://www.finsmes.com/2012/01/rana-therapeutics-closes-20-7m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29&utm_content=Google+Reader
Secondary Venture Round
17.01.2012 – Atlanta, GA
Sharecare Announces $14 Million Growth Equity Financing Led by Galen Partners
Sharecare, an interactive health and wellness social platform providing people with access to expert-developed answers, information and programs to live their healthiest life, today announced that it has secured $14 million growth equity financing led by Galen Partners along with TomorrowVentures, LLC. The proceeds of the financing will enable Sharecare to accelerate the development of innovative programs, services and tools that foster healthier living and unite people across the healthcare continuum to deliver and receive optimal care. http://www.sharecare.com/static/sharecare-announces-14-million-dollar-growth-equity-financing
18.01.2012 – Alpharetta, GA
Carticept Medical Closes $10M Series C Financing Round
Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has has completed a $10 million round of financing, led by existing investors Domain Associates, New Enterprise Associates and SonoSite, Inc. The financing will provide funding for the commercial launch of the Company’s Navigator™ Delivery System (DS), a computer?controlled drug delivery system that redefines medication delivery by integrating ultrasound guidance to increase the efficiency, accuracy and safety of administering medications for joint pain. http://www.carticept.com/press-release-011812.html
17.01.2012 – Brentwood, TN
Change Healthcare Closes Series C with Support from BlueCross BlueShield Venture Partners and Sandbox Industries
Healthcare cost transparency company Change Healthcare Corporation today announced the second closing of its Series C round of funding with investment from BlueCross BlueShield Venture Partners (BCBSVP) and Sandbox Industries. Mitsui & Co. Global Investment, Inc. (MGI) along with the West Health Investment Fund, LLC, and existing investor, Solidus Co., invested in an initial Series C closing in September 2011. In total, the Series C investment of $9.3 million exceeds the Company’s initial fundraising goals. http://www.changehealthcare.com/downloads/releases/2012.01.17%20Change%20Healthcare%20Series%20C%20Funding.pdf
This Week In Venture Capital is brought to you by VM Index from Venture Market Intelligence – Venture Capital made easier
VM Index is an online Life Science, Med Tech & Biotech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.
